In the BioHarmony Drug Report Database

"Preview" Icon

Abarelix

Plenaxis (abarelix) is a protein pharmaceutical. Abarelix was first approved as Plenaxis on 2003-11-25. The pharmaceutical is active against gonadotropin-releasing hormone receptor.

 

Trade Name

 

Plenaxis
 

Common Name

 

abarelix
 

ChEMBL ID

 

CHEMBL1252
 

Indication

 

 

Drug Class

 

Hormone-release inhibiting peptides

Image (chem structure or protein)

Abarelix structure rendering